Literature DB >> 15987610

Restless legs syndrome.

William G Ondo1.   

Abstract

Restless legs syndrome is a very common and still under-diagnosed neurologic condition that can cause severe morbidity. The pathology centers around central nervous system iron homeostatic dysregulation with subsequent alterations in dopaminergic functioning. Genetic studies will hopefully soon identify specific abnormalities. Treatment of restless legs syndrome with dopaminergic medications is highly effective, although augmentation may occur eventually and require dosing flexibility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987610     DOI: 10.1007/s11910-005-0071-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  101 in total

1.  Restless legs syndrome (RLS) in uremic patients is related to the frequency of hemodialysis sessions.

Authors:  Q Huiqi; L Shan; Q Mingcai
Journal:  Nephron       Date:  2000-12       Impact factor: 2.847

2.  Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.

Authors:  N Turjanski; A J Lees; D J Brooks
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

3.  Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron.

Authors:  K A Lee; M E Zaffke; K Baratte-Beebe
Journal:  J Womens Health Gend Based Med       Date:  2001-05

4.  Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions.

Authors:  Z Ye; J R Connor
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

5.  Pramipexole in the treatment of restless legs syndrome: a follow-up study.

Authors:  J Montplaisir; R Denesle; D Petit
Journal:  Eur J Neurol       Date:  2000-05       Impact factor: 6.089

6.  Restless legs syndrome in end-stage renal disease.

Authors:  J W Winkelman; G M Chertow; J M Lazarus
Journal:  Am J Kidney Dis       Date:  1996-09       Impact factor: 8.860

7.  Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome.

Authors:  Svenja Happe; Cornelia Sauter; Gerhard Klösch; Bernd Saletu; Josef Zeitlhofer
Journal:  Neuropsychobiology       Date:  2003       Impact factor: 2.328

8.  Characterizing sleep disorders in chronic hemodialysis patients.

Authors:  J L Holley; S Nespor; R Rault
Journal:  ASAIO Trans       Date:  1991 Jul-Sep

9.  Restless legs syndrome in the elderly.

Authors:  S T O'Keeffe; J Noel; J N Lavan
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

10.  Nocturnal myoclonus and nocturnal myoclonic activity in the normal population.

Authors:  E O Bixler; A Kales; A Vela-Bueno; J A Jacoby; S Scarone; C R Soldatos
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1982-04
View more
  8 in total

Review 1.  Prevalence of restless legs syndrome in North American and Western European populations: a systematic review.

Authors:  Kim E Innes; Terry Kit Selfe; Parul Agarwal
Journal:  Sleep Med       Date:  2011-07-12       Impact factor: 3.492

Review 2.  Sleep problems in children and adolescents with common medical conditions.

Authors:  Amy S Lewandowski; Teresa M Ward; Tonya M Palermo
Journal:  Pediatr Clin North Am       Date:  2011-04-03       Impact factor: 3.278

3.  Treatment of Depression with Vortioxetine in a Patient with Comorbid Major Depressive Disorder and Restless Legs Syndrome: A Case Report.

Authors:  Barış Yilbaş
Journal:  Noro Psikiyatr Ars       Date:  2022-04-28       Impact factor: 1.066

Review 4.  Rotigotine transdermal patch: in restless legs syndrome.

Authors:  Claudine M Baldwin; Gillian M Keating
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 5.  The Prevalence of Restless Legs Syndrome in Patients Undergoing Hemodialysis: A Systematic Review and Meta-analysis Study.

Authors:  Reza Ghanei Gheshlagh; Mohammad Farajzadeh; Mozhdeh Zarei; Vajiheh Baghi; Sahar Dalvand; Kourosh Sayehmiri
Journal:  Basic Clin Neurosci       Date:  2017 Mar-Apr

6.  Reduced neural synchrony in patients with restless legs syndrome during a visual oddball task.

Authors:  Jeong Woo Choi; Deokwon Ko; Gwan-Taek Lee; Ki-Young Jung; Kyung Hwan Kim
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

7.  Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study.

Authors:  Birgit Högl; Diego García-Borreguero; Ralf Kohnen; Luigi Ferini-Strambi; Georgios Hadjigeorgiou; Magdolna Hornyak; Al de Weerd; Svenja Happe; Karin Stiasny-Kolster; Viola Gschliesser; Renata Egatz; Birgit Frauscher; Heike Benes; Claudia Trenkwalder; Wayne A Hening; Richard P Allen
Journal:  J Neurol       Date:  2009-09-11       Impact factor: 4.849

Review 8.  Mitochondrial ferritin in the regulation of brain iron homeostasis and neurodegenerative diseases.

Authors:  Guofen Gao; Yan-Zhong Chang
Journal:  Front Pharmacol       Date:  2014-02-17       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.